Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2.
about
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.Construction, expression and tumor targeting of a single-chain Fv against human colorectal carcinoma.Primary targeting of recombinant Fv-immunotoxin hscFv(25)-mTNFalpha against hepatocellular carcinoma.Different expression systems resulted in varied binding properties of anti-paclitaxel single-chain variable fragment antibody clone 1C2.
P2860
Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Production and validation of t ...... ng of tumors expressing HER-2.
@ast
Production and validation of t ...... ng of tumors expressing HER-2.
@en
type
label
Production and validation of t ...... ng of tumors expressing HER-2.
@ast
Production and validation of t ...... ng of tumors expressing HER-2.
@en
prefLabel
Production and validation of t ...... ng of tumors expressing HER-2.
@ast
Production and validation of t ...... ng of tumors expressing HER-2.
@en
P2093
P356
P1476
Production and validation of t ...... ng of tumors expressing HER-2.
@en
P2093
Bambardieri E
Canevari S
Maffioli L
Mezzanzanica D
de Lalla C
P2888
P304
P356
10.1007/S002620000162
P577
2001-02-01T00:00:00Z
P5875
P6179
1044175110